China Meheco

China Meheco operates as a leading Chinese pharmaceutical group engaged in the import/export, manufacturing, distribution, and retail of pharmaceuticals and medical devices. The company has an extensive commercial portfolio covering small molecules (including antibiotics), biologics/vaccines/blood products/nutritional supplements/herbal medicines/devices. It does not operate like a typical R&D-driven biotech with discrete clinical-stage assets but rather acts as an integrated supply chain leader for health products in China and globally. In recent years it has also entered into major commercialization partnerships such as with Pfizer to distribute Paxlovid for COVID treatment in mainland China. There are no publicly disclosed proprietary drug development programs or clinical trial results.